Comparative Evaluation of Analgesic Outcomes of Intraperitoneal Versus Subcutaneous Administration of Bupivacaine for Laparoscopic Cholecystectomy Patients
Journal of Gandhara Medical and Dental Science · 30.06.2026 · 13 (3) · 81-86
DOI: 10.37762/jgmds.13-3.893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gandhara Medical and Dental Science, online erschienen am 30.06.2026. Verfasst von Nimrah Iqbal und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
OBJECTIVES This study aimed to compare the analgesic efficacy and recovery outcomes of intraperitoneal versus subcutaneous administration of bupivacaine in patients undergoing laparoscopic cholecystectomy. METHODOLOGY This was a comparative clinical study conducted at the Department of Anesthesiology, Rawalpindi Medical University, and at Allied Hospitals. A total of 86 ASA class I patients undergoing elective laparoscopic cholecystectomy were divided into two groups: intraperitoneal bupivacaine (n=43) and subcutaneous port-site infiltration (n=43). Post-operative pain was assessed using the Visual Analog Scale (VAS) at 1, 2, 4, 6, 12, and 24 hours. Time to first rescue analgesia, total analgesic consumption, number of rescue doses, recovery parameters, and complications were recorded. Repeated measures ANOVA, independent sample t-test, and chi-square test were applied, with p ≤ 0.05 considered statistically significant. RESULTSIntraperitoneal bupivacaine significantly reduced post-operative VAS scores at all time intervals (p < 0.001). Repeated-measures ANOVA demonstrated significant effects of time (p < 0.001) and group (p < 0.001), indicating consistently lower pain scores in the intraperitoneal group. Time to first rescue analgesia was longer (211.1±44.1 vs 120.0±44.9 min), and total analgesic consumption was lower (82.7±24.4 vs 125.4±21.1 mg) compared with subcutaneous infiltration (p < 0.001). Patients demonstrated earlier ambulation, earlier oral intake, shorter hospital stay, and higher satisfaction (p < 0.001). Shoulder tip pain was significantly reduced (11.6% vs 46.5%), while other complications were comparable between groups. CONCLUSION Intraperitoneal bupivacaine was associated with improved post-operative analgesia, an enhanced recovery profile, and reduced shoulder tip pain, without increasing complications, compared with subcutaneous infiltration; however, these findings should be interpreted cautiously due to the non-randomized study design.
Zitieren
APA
Iqbal, N., Anjum, W., Rehman, A., Zahir, J., Iqbal, S., & Iqbal, S. (2026). Comparative Evaluation of Analgesic Outcomes of Intraperitoneal Versus Subcutaneous Administration of Bupivacaine for Laparoscopic Cholecystectomy Patients. Journal of Gandhara Medical and Dental Science, 13(3), 81-86. https://doi.org/10.37762/jgmds.13-3.893
Vancouver
Iqbal N, Anjum W, Rehman A, Zahir J, Iqbal S, Iqbal S. Comparative Evaluation of Analgesic Outcomes of Intraperitoneal Versus Subcutaneous Administration of Bupivacaine for Laparoscopic Cholecystectomy Patients. Journal of Gandhara Medical and Dental Science. 2026;13(3):81-86. doi:10.37762/jgmds.13-3.893
BibTeX
@article{Iqbal2026,
author = {Iqbal, Nimrah and Anjum, Waqas and Rehman, Abdul and Zahir, Jawad and Iqbal, Sahar and Iqbal, Sundus},
title = {Comparative Evaluation of Analgesic Outcomes of Intraperitoneal Versus Subcutaneous Administration of Bupivacaine for Laparoscopic Cholecystectomy Patients},
journal = {Journal of Gandhara Medical and Dental Science},
year = {2026},
volume = {13},
number = {3},
pages = {81--86},
doi = {10.37762/jgmds.13-3.893}
}
EUVIMED